In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes
Background: Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common inherited disorder of the mitochondrial fatty acid oxidation, caused by mutations in the ACADM gene. Since the introduction of neonatal screening for MCAD deficiency, a subgroup of newborns have been identified with variant ACADM genotypes that had never been identified before in clinically ascertained patients. In vitro residual MCAD enzyme activity has been found to facilitate risk-stratification. In this study we integrated results of in vitro (residual MCAD enzyme activities) and in vivo (clinical fasting... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2013 |
Reihe/Periodikum: | Touw , C M L , Smit , G P A , Niezen-Koning , K E , Bosgraaf-de Boer , C , Gerding , A , Reijngoud , D-J & Derks , T 2013 , ' In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes ' , Orphanet journal of rare diseases , vol. 8 , 43 . https://doi.org/10.1186/1750-1172-8-43 |
Schlagwörter: | ACADM / Enzyme / Genotype / Fasting / Phenylpropionic acid / CULTURED SKIN FIBROBLASTS / ACID BETA-OXIDATION / MCAD DEFICIENCY / SYNERGISTIC HETEROZYGOSITY / MASS-SPECTROMETRY / CHILDREN / DIAGNOSIS / NETHERLANDS / MUTATIONS / DISEASE |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26827072 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/fabe88ee-8809-4511-a2f3-e389ef53c6cb |